 |
resiquimod |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-24 00:00:00 |
| Sponsor | Galderma Research and Development, LLC;14501 North Freeway;Fort Worth, Texas, 76177 |
Related Access Program
| |
resiquimod |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-24 00:00:00 |
| Sponsor | Galderma Research and Development, LLC;14501 North Freeway;Fort Worth, Texas, 76177 |